Yeast cells expressing differential levels of human or yeast DNA topoisomerase II: a potent tool for identification and characterization of topoisomerase II-targeting antitumour agents Benoît van HilleBridget T. Hill ORIGINAL ARTICLE Pages: 345 - 356
Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells Leslie A. ParselsJoshua D. ParselsJonathan Maybaum ORIGINAL ARTICLE Pages: 357 - 362
Pharmacokinetic analysis of high-dose toremifene in combination with doxorubicin Gregory T. WurzLin SocMichael W. DeGregorio ORIGINAL ARTICLE Pages: 363 - 366
Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone Seiji NaitoShuji KotohThe Kyushu University Urological Oncology Group ORIGINAL ARTICLE Pages: 367 - 372
Drug resistance to 5-aza-2′-deoxycytidine, 2′,2′-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells Nicoletta EliopoulosDenis CournoyerRichard L. Momparler ORIGINAL ARTICLE Pages: 373 - 378
Pharmacokinetics and tissue distribution of the imidazoacridinone C1311 in tumour-bearing mice Christopher R. CalabreseMike C. BibbyPaul M. Loadman ORIGINAL ARTICLE Pages: 379 - 385
The influence of relative body weight on toxicity of combination chemotherapy with cisplatin and etoposide Toshimichi MiyaTomoyuki GoyaYasutsuna Sasaki ORIGINAL ARTICLE Pages: 386 - 390
Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity Sally MullanyPhyllis A. SvingenCharles Erlichman ORIGINAL ARTICLE Pages: 391 - 399
Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol®) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography Abdul-Kader SouidGerald L. NewtonMark L. Bernstein ORIGINAL ARTICLE Pages: 400 - 406
Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker Charles D. ConoverRichard B. GreenwaldKwok L. Shum ORIGINAL ARTICLE Pages: 407 - 414
Phase II trial of titanocene dichloride in advanced renal-cell carcinoma Gerd LümmenHerbert SperlingHerbert Rübben CLINICAL TRIAL REPORT Pages: 415 - 417
Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer Rosario CalvoRosa Ma JiménezAurelio Orjales SHORT COMMUNICATION Pages: 418 - 422
Influence of piperacillin on the pharmacokinetics of methotrexate and 7-hydroxymethotrexate Tawfeeg A. NajjarHisham S. Abou-AudaNaushad M. Ghilzai SHORT COMMUNICATION Pages: 423 - 428
Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo Simon P. LangdonGenevieve J. RabiaszJohn F. Smyth SHORT COMMUNICATION Pages: 429 - 432
